How many institutions own SHPH stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SHPH shares is 9, representing 33.77% of the company's common stock.

Who are the major shareholders selling Shuttle Pharmaceuticals Holdings, Inc. stock?

WELLS FARGO & COMPANY/MN, in the last quarter, reduced its stake in SHPH by -100% restricting it's holding to 0 shares of worth nearly -. RENAISSANCE TECHNOLOGIES LLC also lessened -100% of the SHPH shares from its portfolio, reducing its holding to 0 shares of worth -. UBS GROUP AG also shunned SHPH shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying SHPH stock?

As per its latest 13F filing, VIRTU FINANCIAL LLC increased its stake in SHPH by 21.63% in the last quarter. The institutional holder raised its holding to 12.74 thousand shares having worth more than $5.00K. BANK OF AMERICA CORP /DE/ also added 100% more shares of SHPH to its portfolio, raising its holding to 56 shares of worth $22.00. TOWER RESEARCH CAPITAL LLC (TRC) also increased its SHPH shares holding by 71.71% which brought its holding to 431 shares worth $172.00.

SHPH's major insiders: who are they?

The insider with the most stakes in SHPH is Brown Milton , director at the company. Additionally, SHPH stock is highly held by CEO and Chairman Dritschilo Anatoly and Chief Scientific Officer Jung Mira among others.

Did an insider recently sell SHPH stock?

Company executives, directors, and other insiders own 8.25% percent of Shuttle Pharmaceuticals Holdings, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which SHPH insiders have sold stock, totaling 0 shares. Insiders that have sold shares include JACOBS BETTE, BROWN MILTON, and ADKINS WILLIAM.

Which insider recently purchased SHPH stock?

There have been 0 transaction(s) during the past 6-months in which Shuttle Pharmaceuticals Holdings, Inc. insiders have bought stock, totalling 0 shares

How much of SHPH does insiders own?

Around 0 Shuttle Pharmaceuticals Holdings, Inc. shares are held by insiders, which represents about 8.25% of SHPH stock.

Who is the insider with the largest stake?

SHPH director, Brown Milton holds the largest portfolio of the company's shares. SHPH shares owned by Brown total nearly 1.09 million.

Which institution holds the most shares in SHPH?

VIRTU FINANCIAL LLC is the largest institutional owner in SHPH which holds 12.74 thousand shares worth $5.00K or 0.08% of the total SHPH shares outstanding followed by WELLS FARGO & COMPANY/MN with ownership of 0 shares representing 0% of the SHPH ownership. BANK OF AMERICA CORP /DE/ is the third largest stakeholder with 56 shares or 0% of the ownership worth more than $22.00.

Is Shuttle Pharmaceuticals Holdings, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SHPH is concerned, it is a stock which is not optionable.

Is there a short position on SHPH's shares?

Number of SHPH shares short is 19.82K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding SHPH shares are there?

As of today, 1.07M shares of SHPH are outstanding.

Is there many float in SHPH stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SHPH has 987.08K shares in float.

SHPH short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SHPH is 0.11.

Shuttle Pharmaceuticals (SHPH) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares4.3

Short Percent Of Float4.57

Shares Outstanding1.07M

Shares Float987.08K

Shares Short19.82K

Short Ratio0.11

4.57%

Short % of Float

4.3%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

8.25% Percentage of Shares held by All Insiders

33.77% Percentage of Shares held by All Institutions

36.8% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 33.77% of SHPH shares are held by financial institutions. VIRTU FINANCIAL LLC is the top corporate investor, holding 12.74K shares valued at $5.00K. A 0.08% stake in Shuttle Pharmaceuticals Holdings, Inc. is owned by the company. WELLS FARGO & COMPANY/MN owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2024	VIRTU FINANCIAL LLC	0.08%	12.74K	5K	2.27K	+21.63%
Jun 30, 2024	WELLS FARGO & COMPANY/MN	0%	0	-	-54	-100.00%
Jun 30, 2024	BANK OF AMERICA CORP /DE/	0%	56	22	56	+100.00%
Jun 30, 2024	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-16.5K	-100.00%
Jun 30, 2024	UBS GROUP AG	0%	0	-	-1.12K	-100.00%
Jun 30, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0%	431	172	180	+71.71%
Jun 30, 2024	GEODE CAPITAL MANAGEMENT, LLC	0.19%	30.82K	12.3K	-6.13K	-16.60%
Jun 30, 2024	FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0%	500	200	0	0
Jun 30, 2024	TWO SIGMA SECURITIES, LLC	0.26%	42.29K	16.91K	42.29K	+100.00%
Mar 31, 2024	RENAISSANCE TECHNOLOGIES LLC	0.11%	16.5K	7K	-11.9K	-41.90%
Mar 31, 2024	VIRTU FINANCIAL LLC	0.07%	10.48K	4K	-9.76K	-48.22%
Mar 31, 2024	FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0%	500	203	500	+100.00%
Mar 31, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0%	251	102	151	+151.00%
Mar 31, 2024	WELLS FARGO & COMPANY/MN	0%	54	22	1	+1.89%
Mar 31, 2024	UBS GROUP AG	0.01%	1.12K	455	1.12K	+100.00%
Mar 31, 2024		0%	500	203	500	+100.00%
Mar 31, 2024	GEODE CAPITAL MANAGEMENT, LLC	0.25%	36.96K	15K	0	0
Mar 31, 2024	STONEX GROUP INC.	0%	0	-	-50K	-100.00%
Dec 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0.18%	28.4K	13K	28.4K	+100.00%
Dec 31, 2023	STONEX GROUP INC.	0.32%	50K	23K	50K	+100.00%
Dec 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	100	46	-3	-2.91%
Dec 31, 2023	VIRTU FINANCIAL LLC	0.13%	20.24K	9K	20.24K	+100.00%
Dec 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0.23%	36.96K	16.45K	0	0
Dec 31, 2023	WELLS FARGO & COMPANY/MN	0%	53	24	7	+15.22%
Sep 30, 2023	WELLS FARGO & COMPANY/MN	0%	46	28	46	+100.00%
Sep 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	103	63	103	+100.00%
Sep 30, 2023	GEODE CAPITAL MANAGEMENT, LLC	0.26%	36.96K	22.54K	36.96K	+100.00%
Sep 30, 2023	AYRTON CAPITAL LLC	1.55%	220.43K	134.46K	-30.49K	-12.15%

Insiders

Among the SHPH insiders holding of 8.25% of the stake in company, BROWN MILTON, director, holds the largest shares of 1.09M. DRITSCHILO ANATOLY, CEO and Chairman, is the second largest SHPH insider with ownership of 1.09M shares. JUNG MIRA, Chief Scientific Officer, stands third with possession of 1.07M shares of that stake.

Insiders	Designation	Shares Held
BROWN MILTON	director	1.09M
DRITSCHILO ANATOLY	CEO and Chairman	1.09M
JUNG MIRA	Chief Scientific Officer	1.07M
ADKINS WILLIAM	director	184.07K
JACOBS BETTE	director	27.06K
DRITSCHILO PETER	President and COO	6.56K
VANDER HOEK MICHAEL	Chief Financial Officer	3.85K
SENANAYAKE CHRIS	director	2.79K
RICH TYVIN	Chief Medical Officer	2.43K
RICHARDS STEVEN M	director	1.71K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 13, 2023	JACOBS BETTE	SALE	0.46	4.16K	1.93K	27.06K
Dec 13, 2023	BROWN MILTON	SALE	0.46	2.92K	1.35K	1.09M
Dec 29, 2022	ADKINS WILLIAM	SALE	1.60	995	1.6K	184.07K
Dec 29, 2022	BROWN MILTON	SALE	1.60	995	1.6K	1.07M
Dec 29, 2022	DRITSCHILO ANATOLY	SALE	1.60	8.37K	13.44K	1.09M
Dec 29, 2022	RICH TYVIN	SALE	1.60	1.41K	2.27K	2.43K
Dec 29, 2022	JUNG MIRA	SALE	1.60	328	526.44	1.07M
Dec 29, 2022	JACOBS BETTE	SALE	1.60	4.37K	7.01K	31.22K
Dec 29, 2022	DRITSCHILO PETER	SALE	1.60	3.82K	6.13K	6.56K
Dec 29, 2022	SENANAYAKE CHRIS	SALE	1.60	1.63K	2.61K	2.79K
Dec 29, 2022	VANDER HOEK MICHAEL	SALE	1.60	2.24K	3.6K	3.85K
Dec 29, 2022	RICHARDS STEVEN M	SALE	1.60	995	1.6K	1.71K

SHPH Stock Ownership Breakdown